219 related articles for article (PubMed ID: 8105483)
1. Changes in intra- or extracellular pH do not mediate P-glycoprotein-dependent multidrug resistance.
Altenberg GA; Young G; Horton JK; Glass D; Belli JA; Reuss L
Proc Natl Acad Sci U S A; 1993 Oct; 90(20):9735-8. PubMed ID: 8105483
[TBL] [Abstract][Full Text] [Related]
2. Relationships between rhodamine 123 transport, cell volume, and ion-channel function of P-glycoprotein.
Altenberg GA; Vanoye CG; Han ES; Deitmer JW; Reuss L
J Biol Chem; 1994 Mar; 269(10):7145-9. PubMed ID: 7510282
[TBL] [Abstract][Full Text] [Related]
3. Lower electrical membrane potential and altered pHi homeostasis in multidrug-resistant (MDR) cells: further characterization of a series of MDR cell lines expressing different levels of P-glycoprotein.
Roepe PD; Wei LY; Cruz J; Carlson D
Biochemistry; 1993 Oct; 32(41):11042-56. PubMed ID: 8105888
[TBL] [Abstract][Full Text] [Related]
4. Unidirectional fluxes of rhodamine 123 in multidrug-resistant cells: evidence against direct drug extrusion from the plasma membrane.
Altenberg GA; Vanoye CG; Horton JK; Reuss L
Proc Natl Acad Sci U S A; 1994 May; 91(11):4654-7. PubMed ID: 7910961
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of P-glycoprotein-mediated vinblastine transport across HCT-8 intestinal carcinoma monolayers by verapamil, cyclosporine A and SDZ PSC 833 in dependence on extracellular pH.
Zacherl J; Hamilton G; Thalhammer T; Riegler M; Cosentini EP; Ellinger A; Bischof G; Schweitzer M; Teleky B; Koperna T
Cancer Chemother Pharmacol; 1994; 34(2):125-32. PubMed ID: 7910786
[TBL] [Abstract][Full Text] [Related]
6. Genistein modulates the decreased drug accumulation in non-P-glycoprotein mediated multidrug resistant tumour cells.
Versantvoort CH; Schuurhuis GJ; Pinedo HM; Eekman CA; Kuiper CM; Lankelma J; Broxterman HJ
Br J Cancer; 1993 Nov; 68(5):939-46. PubMed ID: 8105867
[TBL] [Abstract][Full Text] [Related]
7. The role of passive transbilayer drug movement in multidrug resistance and its modulation.
Eytan GD; Regev R; Oren G; Assaraf YG
J Biol Chem; 1996 May; 271(22):12897-902. PubMed ID: 8662680
[TBL] [Abstract][Full Text] [Related]
8. Mechanisms of altered sequestration and efflux of chemotherapeutic drugs by multidrug-resistant cells.
Ouar Z; Lacave R; Bens M; Vandewalle A
Cell Biol Toxicol; 1999 Apr; 15(2):91-100. PubMed ID: 10408356
[TBL] [Abstract][Full Text] [Related]
9. Are altered pHi and membrane potential in hu MDR 1 transfectants sufficient to cause MDR protein-mediated multidrug resistance?
Hoffman MM; Wei LY; Roepe PD
J Gen Physiol; 1996 Oct; 108(4):295-313. PubMed ID: 8894978
[TBL] [Abstract][Full Text] [Related]
10. Probing daunorubicin accumulation defects in non-P-glycoprotein expressing multidrug-resistant cell lines using digitonin.
Versantvoort CH; Broxterman HJ; Feller N; Dekker H; Kuiper CM; Lankelma J
Int J Cancer; 1992 Apr; 50(6):906-11. PubMed ID: 1348241
[TBL] [Abstract][Full Text] [Related]
11. The effect of ion channel blockers, immunosuppressive agents, and other drugs on the activity of the multi-drug transporter.
Weaver JL; Szabo G; Pine PS; Gottesman MM; Goldenberg S; Aszalos A
Int J Cancer; 1993 May; 54(3):456-61. PubMed ID: 7685326
[TBL] [Abstract][Full Text] [Related]
12. Probing the interaction of the multidrug-resistance phenotype with the polypeptide ionophore gramicidin D via functional channel formation.
Assaraf YG; Borgnia MJ
Eur J Biochem; 1994 Jun; 222(3):813-24. PubMed ID: 7517866
[TBL] [Abstract][Full Text] [Related]
13. Non-P-glycoprotein multidrug resistance in cell lines which are defective in the cellular accumulation of drug.
Center MS
Cytotechnology; 1993; 12(1-3):109-25. PubMed ID: 7765322
[TBL] [Abstract][Full Text] [Related]
14. P-glycoprotein as multidrug transporter: a critical review of current multidrug resistant cell lines.
Nielsen D; Skovsgaard T
Biochim Biophys Acta; 1992 Jul; 1139(3):169-83. PubMed ID: 1352705
[TBL] [Abstract][Full Text] [Related]
15. P-glycoprotein: multidrug-resistance and a superfamily of membrane-associated transport proteins.
Juranka PF; Zastawny RL; Ling V
FASEB J; 1989 Dec; 3(14):2583-92. PubMed ID: 2574119
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of drug transport by genistein in multidrug-resistant cells expressing P-glycoprotein.
Castro AF; Altenberg GA
Biochem Pharmacol; 1997 Jan; 53(1):89-93. PubMed ID: 8960067
[TBL] [Abstract][Full Text] [Related]
17. Preferential expression and activity of multidrug resistance gene 1 product (P-glycoprotein), a functionally active efflux pump, in human CD8+ T cells: a role in cytotoxic effector function.
Gupta S; Kim CH; Tsuruo T; Gollapudi S
J Clin Immunol; 1992 Nov; 12(6):451-8. PubMed ID: 1363104
[TBL] [Abstract][Full Text] [Related]
18. Functional studies with a full-length P-glycoprotein cDNA encoded by the hamster pgp1 gene.
Devine SE; Melera PW
Cancer Chemother Pharmacol; 1994; 33(6):465-71. PubMed ID: 7907953
[TBL] [Abstract][Full Text] [Related]
19. Functional imaging of multidrug-resistant P-glycoprotein with an organotechnetium complex.
Piwnica-Worms D; Chiu ML; Budding M; Kronauge JF; Kramer RA; Croop JM
Cancer Res; 1993 Mar; 53(5):977-84. PubMed ID: 8094997
[TBL] [Abstract][Full Text] [Related]
20. Biophysical aspects of P-glycoprotein-mediated multidrug resistance.
Wadkins RM; Roepe PD
Int Rev Cytol; 1997; 171():121-65. PubMed ID: 9066127
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
